We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Case study from the ExaInformatics who pitched their ideas to industry and investors at the CDE Marketplace on 6 September 2016.
Ten British companies, members of EBLEX, a British organisation responsible for promoting British meat exports, visited Kinshasa
Case study from Plextek who pitched their ideas to industry and investors at the CDE Marketplace on 27 April 2016.
Summary List of field safety notices (FSNs) from medical device manufacturers from 27 - 31 March 2017
(Dextro)propoxyphene can have serious effects on the electrical activity of the heart (resulting in prolongation of the P-R and Q-T intervals, and widened QRS complexes), even at normal therapeutic doses.
The government has referred the legal high 'mexxy' to drug experts in a move which could lead to a temporary ban.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
A new advanced imaging centre will receive £81 million government support, housing super-bright lasers to produce state-of-the-art 3D X-rays in just 40 seconds.
The CMA carried out a market study into digital comparison tools (DCTs) to see how they are working for consumers, businesses and the economy.
Letters were sent about Cetrotide (cetrorelix acetate), Eperzan▼(albiglutide), darunavir/cobicistat, Keytruda▼ (pembrolizumab), Denzapine (clozapine) 50 mg/mL oral suspension, and Bleo-Kyowa (bleomycin sulphate).
CSL Behring is recalling the listed batches due to reduced potency of the active ingredient.
Dstl and industry have been putting wearable technology to the test.
Letters were sent about cladribine (Litak and Leustat), radium-223-dichloride (Xofigo▼), and ERWINASE.
A new framework, known as 'Stone Soup' has been developed by 5-eyes nations and led by Dstl.
Letters were sent in September about Dacogen (decitabine), Eperzan▼(albiglutide), ERWINASE, ReoPro (abciximab), and recombinant human erythropoietins.
The government has used a temporary class drug order for the first time to ban the ‘legal high’ methoxetamine, also called ‘mexxy’ or MXE. From…
From October 2014 Dexamethasone 4 mg/ml injection (Organon Laboratories Limited) will be replaced by Dexamethasone 3.8 mg/ml solution for injection (Aspen Pharma Trading Limited).
DFID Central Asia conducted annual review of its Equity programme implemented by UNICEF in southern Kyrgyzstan.
Case study from Conekt who pitched their ideas to industry and investors at the CDE Marketplace on 6 September 2016.
(Allergan UK Limited) Specific batch including a Danish language pack was shipped to the UK in error. Class 3 – action within 5 days. (EL (15)A/03)
Ecolab are recalling batches of Klerpack BD Syringe Multi-Pack as the sterile packaging may contain small holes in the film of the pouch. (EL (16)A/13)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).